Harper Sean E's Form 4 filing
ACELYRIN, Inc.SLRN · filed May 11, 2023
- Accession no.
- 0001209191-23-028886
- Filed
- May 11, 2023, 9:16 PM ET
- Trade date
- May 9, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions and 3 derivative transactions. Open-market purchases total $22.5M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Harper Sean ECIK 0001541946 | 10% Owner |
| Westlake BioPartners Fund II, L.P.CIK 0001811947 | 10% Owner |
| Westlake BioPartners GP II, LLCCIK 0001811948 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 9, 2023 | Common Stock | CConversionAcquired | +8,540,729 | –F1 | – | 8,540,729 | Direct | Duplicate filing |
| May 9, 2023 | Common Stock | PPurchaseAcquired | +1,250,000 | $18.00 | +$22,500,000 | 9,790,729 | Direct | Duplicate filing |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 9, 2023 | Common Stock | CConversionDisposed | −4,056,795 | –F5 | – | 0 | Direct | Duplicate filing |
| May 9, 2023 | Common Stock | CConversionDisposed | −2,445,786 | –F5 | – | 0 | Direct | Duplicate filing |
| May 9, 2023 | Common Stock | CConversionDisposed | −2,038,148 | –F5 | – | 0 | Direct | Duplicate filing |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
Represents shares of Common Stock received upon conversion of shares of the reported series of preferred stock on a one-for-one basis without payment of further consideration.
Referenced by the price of 1 transaction in Table I.
- F5
Each share of preferred stock is convertible into one share of Common Stock and has no expiration date. Immediately prior to the completion of the IPO, all shares of preferred stock automatically converted into shares of Common Stock.
Referenced by the price of 3 transactions in Table II.